Literature DB >> 12559674

Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality.

Betsy Foxman1, Kelly L Klemstine, Patricia D Brown.   

Abstract

PURPOSE: To describe the 1997 incidence of hospitalization for acute pyelonephritis in the US and the risk factors for in-hospital mortality associated with acute pyelonephritis.
METHODS: Cases were defined as those with ICD9-CM codes corresponding to acute pyelonephritis in the 1997 Health Care Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS). Frequencies and calculations were weighted to produce either national or state estimates. Hospitalization rates were calculated using 1997 US Census Bureau population projections for the denominator.
RESULTS: Females were almost five times as likely as males to be hospitalized for acute pyelonephritis (11.7/10,000 vs. 2.4/10,000), but males had higher mortality rates (16.5/1000 vs. 7.3/1000); 30% greater after adjustment. Hospitalization and in-hospital mortality rates increased with age, but not with diabetes. Mortality rates increased with number of procedures, diagnoses and having a major diagnostic category other than disorders of the kidney and urinary tract. Persons living in zip codes with lower median incomes were also at higher risk of mortality. There was little variation in mortality by hospital size, ownership, location or teaching status.
CONCLUSION: In hospital mortality for pyelonephritis was associated with patient rather than hospital characteristics suggesting uniform application of standard care across hospitals and populations.

Entities:  

Mesh:

Year:  2003        PMID: 12559674     DOI: 10.1016/s1047-2797(02)00272-7

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  50 in total

1.  Androgens Enhance Male Urinary Tract Infection Severity in a New Model.

Authors:  Patrick D Olson; Keith A Hruska; David A Hunstad
Journal:  J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 10.121

2.  Hyperresistinemia - a novel feature in systemic infection during human pregnancy.

Authors:  Shali Mazaki-Tovi; Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Giovanna Ogge; Bo Hyun Yoon; Zhong Dong; Juan M Gonzalez; Maria Teresa Gervasi; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-02-18       Impact factor: 3.886

3.  Association between mannose-binding lectin deficiency and septic shock following acute pyelonephritis due to Escherichia coli.

Authors:  Alex Smithson; Ana Muñoz; Belen Suarez; Sara Maria Soto; Rafael Perello; Alex Soriano; Jose Antonio Martinez; Jordi Vila; Juan Pablo Horcajada; Jose Mensa; Francisco Lozano
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

4.  Prediction of complicated urinary tract infections in patients with type 2 diabetes: a questionnaire study in primary care.

Authors:  Leonie M A J Venmans; Marian Sloof; Eelko Hak; Kees J Gorter; Guy E H M Rutten
Journal:  Eur J Epidemiol       Date:  2007-01-03       Impact factor: 8.082

5.  Susceptibility of Urinary Tract Bacteria to Newer Antimicrobial Drugs.

Authors:  Manjula Mehta; Jyoti Sharma; Sonia Bhardwaj
Journal:  Open Access Maced J Med Sci       Date:  2016-01-25

6.  The potential impact of biomarker-guided triage decisions for patients with urinary tract infections.

Authors:  A Litke; R Bossart; K Regez; U Schild; M Guglielmetti; A Conca; P Schäfer; B Reutlinger; B Mueller; W C Albrich
Journal:  Infection       Date:  2013-02-24       Impact factor: 3.553

Review 7.  Urinary Tract Infection: Pathogenesis and Outlook.

Authors:  Lisa K McLellan; David A Hunstad
Journal:  Trends Mol Med       Date:  2016-09-28       Impact factor: 11.951

8.  Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis.

Authors:  Shali Mazaki-Tovi; Edi Vaisbuch; Roberto Romero; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Sun Kwon Kim; Chia-Ling Nhan-Chang; Ricardo Gomez; Bo H Yoon; Lami Yeo; Pooja Mittal; Giovanna Ogge; Juan M Gonzalez; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2010-01-19       Impact factor: 3.886

Review 9.  Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection.

Authors:  Ana Flores-Mireles; Teri N Hreha; David A Hunstad
Journal:  Top Spinal Cord Inj Rehabil       Date:  2019

10.  Treatment duration of febrile urinary tract infection (FUTIRST trial): a randomized placebo-controlled multicenter trial comparing short (7 days) antibiotic treatment with conventional treatment (14 days).

Authors:  Cees van Nieuwkoop; Jan W van't Wout; Willem J J Assendelft; Henk W Elzevier; Eliane M S Leyten; Ted Koster; G Hanke Wattel-Louis; Nathalie M Delfos; Hans C Ablij; Ed J Kuijper; Jan Pander; Jeanet W Blom; Ida C Spelt; Jaap T van Dissel
Journal:  BMC Infect Dis       Date:  2009-08-19       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.